Impact of rapid molecular testing on diagnosis, treatment and management of community-acquired pneumonia in Norway: a pragmatic randomised controlled trial (CAPNOR)

Peer Review reports

Original Submission
28 Mar 2022	Submitted	Original manuscript
2 May 2022	Reviewed	Reviewer Report - Riaz Qureshi
25 May 2022	Author responded	Author comments - Sondre Serigstad
Resubmission - Version 2
25 May 2022	Submitted	Manuscript version 2
5 Jun 2022	Reviewed	Reviewer Report - Riaz Qureshi
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
9 Jun 2022	Editorially accepted
1 Aug 2022	Article published	10.1186/s13063-022-06467-7

Back to article page